Cobicistat
A pharmacokinetic enhancer used in antiretroviral therapy
Cobicistat is a pharmacokinetic enhancer used in combination with other antiretroviral drugs for the treatment of HIV/AIDS. It is not active against HIV itself but enhances the effectiveness of other drugs by inhibiting the cytochrome P450 3A (CYP3A) enzymes, which are responsible for the metabolism of many antiretroviral drugs.
Mechanism of Action[edit | edit source]
Cobicistat works by inhibiting the CYP3A enzymes in the liver and intestines. This inhibition leads to increased plasma concentrations of drugs that are metabolized by these enzymes, such as atazanavir and darunavir. By boosting the levels of these drugs, cobicistat allows for lower doses to be used, reducing the potential for side effects and improving patient adherence to therapy.
Clinical Use[edit | edit source]
Cobicistat is used as a component of fixed-dose combination therapies for the treatment of HIV-1 infection. It is commonly found in combination with other antiretrovirals such as elvitegravir, emtricitabine, and tenofovir. These combinations are used in once-daily regimens that simplify treatment and improve adherence.
Pharmacokinetics[edit | edit source]
Cobicistat is absorbed in the gastrointestinal tract and reaches peak plasma concentrations approximately 3 to 4 hours after oral administration. It is extensively metabolized in the liver, primarily by CYP3A and CYP2D6 enzymes, and is excreted in the feces and urine.
Side Effects[edit | edit source]
Common side effects of cobicistat include nausea, diarrhea, and fatigue. It can also cause increases in serum creatinine due to inhibition of renal tubular secretion, which may lead to reduced kidney function in some patients. Monitoring of renal function is recommended during treatment.
Drug Interactions[edit | edit source]
Due to its mechanism of action, cobicistat can interact with a wide range of drugs that are metabolized by CYP3A enzymes. It is important to review a patient's medication list for potential interactions and adjust dosages accordingly.
Related pages[edit | edit source]
Cobicistat
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
